2025 Conference

Welcome Letter

Dear Industry Colleagues,

On behalf of IATI and the organizing committee, it is our utmost pleasure to invite you to join MIXiii Health-Tech.IL 2025, the premier conference and exhibition in the field of life science in Israel. The conference will take place at the International Convention Center (ICC), Jerusalem, March 4-5, 2025.

MIXiii Health-Tech IL. Conference is led and organized by IATI, Israel’s umbrella organization of the entire high-tech, life sciences, and advanced technology industries. The association works to strengthen and promote Israel’s thriving life science and technology sector by creating an environment that supports innovation, developing international business connections, promoting collaborations between industry and academia, and influencing government policy.

We are delighted to host this prestigious Health-Tech and Life Science conference which aims to bring together leading researchers, scientists, professionals, entrepreneurs, investors and academia from around the globe. Over the course of two days, we anticipate fruitful discussions, knowledge exchange and collaborative opportunities that will help shape the future of the life sciences industry.

The innovative spirit within Israel’s life sciences sector has led to significant breakthroughs in recent years, especially in areas where these disciplines intersect. The synergy between engineering and biology, coupled with the rapidly growing field of digital health and remote medicine, has paved the way for cutting-edge solutions that are poised to make a profound impact on global healthcare. The expertise developed in these domains is not only impressive but also indicative of the forward-thinking approach that Israeli companies are known for.

We have meticulously crafted a diverse program, comprising of keynote speeches, panel discussions, breakout sessions, workshops, start-up competitions, and poster presentations, to ensure a comprehensive and engaging experience for all attendees. Organized by the industry and for the industry, MIXiii Health-Tech.IL is heavily supported by various Israeli government offices and sponsored by key companies in the health care space.

In addition to the scientific program, we are organizing social events and networking opportunities to enhance your experience and facilitate meaningful interactions with fellow delegates. This will be a great chance to forge new partnerships, exchange ideas, and build lasting connections within the life science community.

We look forward to welcoming you all to the MIXiii Health-Tech.IL and creating a memorable and impactful experience for everyone involved.

Karin Mayer Rubinstein
CEO & President
Israel Advanced Technology Industries Association (IATI)

Yaacov Michlin
Conference Chair
CEO – BioLight Life Sciences Ltd.

Among Our Speakers

Moshe Leon, Mayor of Jerusalem
Dr. Peter Kash, Chairman, Camelot BioCapital
Stefan Oschmann, Former Chairman of the Executive Board and CEO of Merck Group
Dr. Jeremy Levin, Chairman and CEO, Ovid Therapeutics Inc.
Prof. Eli Sprecher, CEO, Tel Aviv Sourasky Medical Center
Oded Spindel, Ph.D., MBA, Senior Vice President, Investment Banking, H.C. Wainwright & Co., LLC
Dror Bin, CEO, Israel Innovation Authority
Mori Arkin, Founder & Chairman, Arkin Holdings
Prof. Chaim Lotan, MD, FACC, FESC, Chief Innovation Officer, Hadassah – Hebrew University Medical
Dr. Giora Yaron, Founding Investor and Chairman of the Board, Itamar Medical
Prof. Yoram G. Weiss, MD, MBA, FCCM, Director General, Hadassah Medical Organization
Prof. Aaron Palmon, DMD, Ph.D., Vice President for Research and Development, The Hebrew University of Jerusalem
Eran Harry, SVP, Global Head of Early Clinical Development, Global R&D, Teva Pharmaceuticals
Yaron Shilat, Director of Public Policy Israel, Innovation Policies EMEA at Amazon Web Services, AWS
Dr. Tehila Ben Moshe, Ph.D., Chief Executive Officer, Biond Biologies
Dr. Anat Ekka-Zohar, Ph.D., Health Consulting & Entrepreneurship
Dr. Vered Bar, Vice President Research & Development, CURESPONSE
Hadas Klein, Health Cluster Manger, The National Program for Economic Growth
Mati Gill, CEO, AION Labs
Karin Noy, Senior Director Emerging Science & Innovation Lead Technology & AI, Pfizer
Zur Genosar, Co-Founder & CEO, Hoffman Kofman Foundation

Program Topics

MIXIII Conference Topic 2025

2025 MIXiii Health-Tech.IL Steering Committee

Mr. Yaacov Michlin
Mr. Yaacov MichlinConference Chair & CEO, BioLight Life Sciences Ltd
Karin Mayer Rubinstein
Karin Mayer RubinsteinCEO & President, Israel Advanced Technology Industries (IATI)
Prof. Irit Sagi
Prof. Irit SagiVP for Innovation & Technology Transfer, Weizmann Institute of Science
Shai Melcer, PhD
Shai Melcer, PhDHead of the National Bio-convergence Program Technology Division, Israel Innovation Authority
Regine Shevach
Regine ShevachHealthcare Business Consultant Former Country Speaker & Managing Director of Merck Biopharma & Electronics (Israel)
Liron Dover
Liron DoverHead of Bio Jerusalem & JNext, The Jerusalem Development Authority